Endocardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment: A 26-Week (with 26 Week Extension) Phase 2b Randomized, Multi-Center, Double-Blind, Sham Controlled Study to Evaluate Efficacy and Safety
Clinical Trial Grant
Administered By
Surgery, Cardiovascular and Thoracic Surgery
Awarded By
XyloCor Therapeutics
Start Date
July 4, 2025
End Date
July 31, 2033
Administered By
Surgery, Cardiovascular and Thoracic Surgery
Awarded By
XyloCor Therapeutics
Start Date
July 4, 2025
End Date
July 31, 2033